CNBC May 17, 2019
KEY POINTS
- J.P. Morgan Chase is buying medical payments technology firm InstaMed to push more deeply into the $3.5 trillion market for U.S. health-care spending.
- The deal for more than $500 million shows that the nation’s largest bank views the fast-changing world of payments as a battleground worthy of aggressive wagers.
- InstaMed, founded in 2004 by a pair of former Accenture consultants, automates medical billing with electronic rails for the delivery of health-care information and payments.
J.P. Morgan Chase is buying medical payments technology firm InstaMed to push more deeply into the $3.5 trillion market for U.S. health-care spending.
The bank agreed on Friday to purchase the Philadelphia-based company of about 300 employees that processed...
Today's Sponsors
Today's Sponsor